MDCK-QIV
/ Sinopharm
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 19, 2025
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
(clinicaltrials.gov)
- P1 | N=300 | Completed | Sponsor: Shanghai Institute Of Biological Products | Recruiting ➔ Completed
Trial completion • Infectious Disease • Influenza • Respiratory Diseases
May 31, 2024
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
(clinicaltrials.gov)
- P1 | N=300 | Recruiting | Sponsor: Shanghai Institute Of Biological Products | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Influenza • Respiratory Diseases
1 to 2
Of
2
Go to page
1